Medical Center Medconsult Pleven OOD — Clinical Trial Site

115 Registered trials

51 Currently recruiting

Organisation

Medical Center Medconsult Pleven OOD

Location

Pleven, Bulgaria

Identifier

ORG-100042701

Address

Ulitsa Tirgovska 12, 5500, Bulgaria

Departments

#204
#205: Rheumatology
#2206
#3009
#3119
#40313
#40313; Rheumatology
#7405
#9003
0401: Dermatology
0403: Dermatology
0905: NAP
10019:Internal Medicine Office
1301: Dermatology
1302: NAP
1505
2004
3501
3502
4003
4009
41001
41004
4108
502_Not applicable
503_Not applicable
601: NA
602: NA
7304: NA
8005:
BG004
BG010
BG10006
BGR03291: Dermatology
BGR03292
Cardiology
Cardiology Consulting Room
Dermato-venerology
Dermatology
Dermatology room
Endocrinology and Metabolic Diseases Consulting Room
Internal Medicine
N.A
N/A
NA
No department
Not applicable
Physician Office of Rheumatology
Psychiatric Office
Psychiatry

Clinical trials at this site (115)

Search interface

A Clinical Study that will measure how well SEP-363856 works and how safe it is in adults with Generalized Anxiety Disorder Ended

2022-502077-42-00 generalised anxiety disorder 10 2023-09-14
ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Ended

2022-500535-36-01 Moderately to severely active ulcerative colitis 5 2023-06-12
A rollover study for subjects that complete KAR-012 trial, to assess Long-term Safety and Tolerability of Adjunctive KarXT in Subjects with … Ended

2024-510773-20-00 Schizophrenia 5 2023-06-12
Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) in Combination with Topical Corticosteroids and/or Topical … Ended

2022-501585-22-00 Atopic Dermatitis 5 2023-05-11
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients with Mild-to-Moderate Ulcerative Colitis Ended

2024-512558-40-00 Mild-to-moderate ulcerative colitis 4 2023-05-11
A study to test if izokibep improves psoriatic arthritis symptoms and to see how safe izokibep is Ended

2022-501362-22-00 Psoriatic Arthritis 10 2023-04-18
Protocol Lay Person Short Title: A Trial of the Safety and Efficacy of Flexible Doses of SEP-363856 as Adjunctive Therapy in the Treatment o… Ended

2022-500538-27-00 Adjunctive therapy to antidepressants for the treatmen 10 2023-03-30
A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia (ARISE) Ended

2024-510770-25-00 Schizophrenia 5 2023-03-22
A 52-week, Open-label Trial of CVL-231 in Adult Participants With Schizophrenia Ended

2024-511441-19-00 Schizophrenia 4 2023-03-08
A study to learn how well the drug EDP-938 works and how safe it is for non-hospitalized Adults with Acute Respiratory Syncytial Virus Infec… Ended

2024-513861-38-00 Respiratory syncytial virus (RSV) 4 2023-02-02
Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment in Subjects with Schizophrenia Ended

2023-508433-14-00 Schizophrenia 5 2022-09-30
A study comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF5993 With the Fixed Dose Dual Combination CHF153… Ended

2023-510172-31-00 Chronic obstructive pulmonary disease (COPD) 5 2022-04-22
Study to understand if inclisiran is better than a placebo at lowering LDL-cholesterol,is safe and can have an impact on patient quality of … Ended

2024-511263-28-00 Hypercholesterolemia 6 2022-04-08
A Study to Evaluate the Efficacy and Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Ended

2023-507093-40-00 Chronic Obstructive Pulmonary Disease (COPD) 4 2022-01-27
An extension study to learn if Bimekizumab is safe and works as a long-term therapy in adults with moderate to severe hidradenitis suppurati… Ended

2024-511035-10-00 Hidradenitis Suppurativa 5 2021-06-23
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's … Ended

2023-504990-19-00 Agitation in Patients With Dementia of the Alzheimer's 5 2021-04-06
An open-label study evaluating ofatumumab treatment effectiveness and PROs in subjects with RMS transitioning from fumarate-based RMS approv… Ended

2023-507493-41-00 relapsing multiple sclerosis (RMS) 5 2020-08-04
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 Adults at high risk of cardiovascular events without pr 5 2019-05-24
CHRONDI Ended

2024-513595-17-00 CHRONIC PAIN DUE TO DIABETIC PERIPHERAL NEUROPATHY 4